Sotalol Hydrochloride Tablet
Product Images NDC 42806-121

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 42806-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120mg 100ct

The label for Sotalol Hydrochloride Tablets USP (AF) 120 mg by Epic Pharma, LLC. The label displays dosage storage instructions, a note to dispense accompanying patient information leaflets, and a warning to keep medication out of children’s reach. It indicates the package contains 100 tablets and includes a barcode and manufacturer information.*

FDA Label Image

160mg 100ct

Label for Sotalol Hydrochloride Tablets USP (AF) 160 mg, oral tablets by Epic Pharma, LLC. The label includes dosage information, storage instructions, and a note to dispense accompanying patient information. The package contains 100 tablets for prescription use only.*

FDA Label Image

80mg 100ct

Label for Sotalol Hydrochloride Tablets USP (AF) 80 mg by Epic Pharma, LLC. The label includes dosage form (tablet), strength (80 mg), quantity (100 tablets), and storage instructions (20°-25°C). It indicates the product is prescription-only and includes warnings to keep tightly closed and out of reach of children.*

FDA Label Image

Age Graph

A line graph depicting Age Factor as a function of Age in months. The Age Factor increases from about 0.2 at 0.1 month to 1.0 at 24 months and above, indicating a scaled relationship between age and an unspecified factor.*

FDA Label Image

Figure-1-study-1 (Figure 1 Study 1)

A Kaplan-Meier survival curve chart depicting recurrence-free survival over 360 days for sotalol hydrochloride tablets at 80 mg, 120 mg, 160 mg doses compared to placebo. The y-axis represents recurrence-free survival probability (0.0 to 1.0), and the x-axis represents time in days. P-values for each dose versus placebo are shown using Log-Rank test results.*

FDA Label Image

Figure-2-study-2 (Figure 2 Study 2)

A Kaplan-Meier survival curve chart comparing recurrence-free survival over 180 days between Sotalol Hydrochloride Tablets (AF) and placebo groups. The y-axis represents recurrence-free survival probability from 0 to 1.0, and the x-axis shows time in days from 0 to 180. The Sotalol Hydrochloride group shows a higher survival curve than placebo, with a log-rank p-value of 0.002, indicating statistical significance.*

FDA Label Image

Steps Diagram

A text panel providing monitoring instructions for sotalol hydrochloride tablets, including telemetry placement, QT interval evaluation with contraindications if QT > 450 msec, calculation of creatinine clearance to guide dosing and contraindications, and guidelines for QT monitoring 2 to 4 hours after each dose including dose adjustments and discontinuation criteria.*

FDA Label Image

Structure Formula

Chemical structure diagram of sotalol hydrochloride, showing the molecular composition and bonding arrangement of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.